<table border="0" cellpadding="2" cellspacing="1" id="i8a6e2da3-a9c2-4163-8246-6a387bf10e30" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 20: HIV RNA Response by Number and Type of Baseline PI Substitution, Antiretroviral-Experienced Patients in Study AI424-045, As-Treated Analysis</caption>
<colgroup>
<col width="36%"></col>
<col width="32%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr valign="bottom">
<th align="center" rowspan="2" stylecode="Toprule Botrule">
<content stylecode="bold">Number and Type of Baseline PI Substitutions<sup>a</sup>
</content>
</th>
<th align="center" colspan="2" rowspan="1" stylecode="Toprule">
<content stylecode="bold">Virologic Response = HIV RNA &lt;400 copies/mL<sup>b</sup>
</content>
</th>
</tr>
<tr valign="bottom">
<th align="center" colspan="1" rowspan="1" stylecode="Botrule">
<content stylecode="bold">ATV/RTV<br/>(n=110)</content>
</th>
<th align="center" colspan="1" rowspan="1" stylecode="Botrule">
<content stylecode="bold">LPV/RTV<br/>(n=113)</content>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="3" rowspan="1" stylecode="Toprule">
<sup>a</sup> Primary substitutions include any change at D30, V32, M36, M46, I47, G48, I50, I54,
A71, G73, V77, V82, I84, N88, and L90. </td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">
<sup>b</sup> Results should be interpreted with caution because the subgroups were small.</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" stylecode="Botrule">
<sup>c</sup> There were insufficient data (n&lt;3) for PI substitutions V32I, I47V, G48V, I50V,
and F53L.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1" stylecode="Toprule">
<content stylecode="bold">3 or more primary PI substitutions including:<sup>c</sup>
</content>
</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   D30N</td>
<td align="center" colspan="1" rowspan="1">75% (6/8)</td>
<td align="center" colspan="1" rowspan="1">50% (3/6)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   M36I/V</td>
<td align="center" colspan="1" rowspan="1">19% (3/16)</td>
<td align="center" colspan="1" rowspan="1">33% (6/18)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   M46I/L/T</td>
<td align="center" colspan="1" rowspan="1">24% (4/17)</td>
<td align="center" colspan="1" rowspan="1">23% (5/22)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   I54V/L/T/M/A</td>
<td align="center" colspan="1" rowspan="1">31% (5/16)</td>
<td align="center" colspan="1" rowspan="1">31% (5/16)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   A71V/T/I/G</td>
<td align="center" colspan="1" rowspan="1">34% (10/29)</td>
<td align="center" colspan="1" rowspan="1">39% (12/31)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   G73S/A/C/T</td>
<td align="center" colspan="1" rowspan="1">14% (1/7)</td>
<td align="center" colspan="1" rowspan="1">38% (3/8)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   V77I</td>
<td align="center" colspan="1" rowspan="1">47% (7/15)</td>
<td align="center" colspan="1" rowspan="1">44% (7/16)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   V82A/F/T/S/I</td>
<td align="center" colspan="1" rowspan="1">29% (6/21)</td>
<td align="center" colspan="1" rowspan="1">27% (7/26)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   I84V/A</td>
<td align="center" colspan="1" rowspan="1">11% (1/9)</td>
<td align="center" colspan="1" rowspan="1">33% (2/6)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   N88D</td>
<td align="center" colspan="1" rowspan="1">63% (5/8)</td>
<td align="center" colspan="1" rowspan="1">67% (4/6)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">   L90M</td>
<td align="center" colspan="1" rowspan="1">10% (2/21)</td>
<td align="center" colspan="1" rowspan="1">44% (11/25)</td>
</tr>
<tr valign="top">
<td align="left" colspan="3" rowspan="1">
<content stylecode="bold">Number of baseline primary PI substitutions<sup>a</sup>
</content>
</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">All patients, as-treated</td>
<td align="center" colspan="1" rowspan="1">58% (64/110)</td>
<td align="center" colspan="1" rowspan="1">59% (67/113)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">0–2 PI substitutions</td>
<td align="center" colspan="1" rowspan="1">75% (50/67)</td>
<td align="center" colspan="1" rowspan="1">75% (50/67)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">3–4 PI substitutions</td>
<td align="center" colspan="1" rowspan="1">41% (14/34)</td>
<td align="center" colspan="1" rowspan="1">43% (12/28)</td>
</tr>
<tr valign="top">
<td align="left" colspan="1" rowspan="1">5 or more PI substitutions</td>
<td align="center" colspan="1" rowspan="1">0% (0/9)</td>
<td align="center" colspan="1" rowspan="1">28% (5/18)</td>
</tr>
</tbody>
</table>